Hasil Pencarian (1)
small molecule | CAS: 2097132-94-8
Pralsetinib, similar to the previously approved [selpercatinib], is a kinase inhibitor with enhanced specificity for RET tyrosine kinase receptors (RTKs) over other RTK classes.[A202055, A219751, L15986] Enhanced RET (Rearranged during transfection) oncogene …
Kategori:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 Inhibitors
+38
Target Protein:
Proto-oncogene tyrosine-protein kinase receptor RetEpithelial discoidin domain-containing receptor 1NT-3 growth factor receptor
+8
Waktu ParuhPralsetinib has a p…
Vol. DistribusiPralsetinib has a m…
KlirensPralsetinib has a m…
Genetik
-